<DOC>
	<DOC>NCT00982527</DOC>
	<brief_summary>The purpose of this study is to determine whether fenoldopam infusion during cardiopulmonary bypass in young children with congenital heart disease is able to reduce indicators of acute kidney injury (biomarkers reduction, diuresis increase) compared to a control group.</brief_summary>
	<brief_title>Fenoldopam in Pediatric Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Fenoldopam</mesh_term>
	<criteria>Children with congenital heart disease, less than one year old, undergoing surgery with the use of cardiopulmonary bypass Children over one year old, correction for ventricular or atrial septal defect, need for deep hypothermic circulatory arrest, preoperative renal dysfunction.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>365 Days</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>cardiopulmonary bypass</keyword>
	<keyword>pediatric cardiac surgery</keyword>
	<keyword>acute renal failure</keyword>
	<keyword>renal biomarkers</keyword>
	<keyword>fenoldopam</keyword>
	<keyword>Focus on optimization of perfusion during pediatric CPB</keyword>
</DOC>